CS logo
small CS logo
Aurora Bay Area Medical Group-Marinette

Marinette, Wisconsin, United States
Hospital in Marinette County, Wisconsin
3003 University Dr, Marinette, WI 54143

About Aurora Bay Area Medical Group-Marinette


Bay Area Medical Center is a 99-bed general acute care hospital located in Marinette, Wisconsin. Bay Area Medical Center was constructing a new facility in Marinette.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Aurora Bay Area Medical Group-Marinette


During the past decade, Aurora Bay Area Medical Group-Marinette conducted 127 clinical trials. In the 10-year time frame, 127 clinical trials started and 216 clinical trials were completed, i.e. on average, 170.1% percent of trials that started reached the finish line to date. In the past 5 years, 50 clinical trials started and 84 clinical trials were completed. i.e. 168% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Aurora Bay Area Medical Group-Marinette" #1 sponsor was "National Cancer Institute (NCI)" with 135 trials, followed by "Alliance for Clinical Trials in Oncology" with 79 trials sponsored, "SWOG Cancer Research Network" with 44 trials sponsored, "Radiation Therapy Oncology Group" with 30 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 30 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 18 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Aurora Bay Area Medical Group-Marinette" #1 collaborator was "National Cancer Institute (NCI)" with 235 trials as a collaborator, "NRG Oncology" with 62 trials as a collaborator, "Cancer and Leukemia Group B" with 16 trials as a collaborator, "NCIC Clinical Trials Group" with 13 trials as a collaborator and "SWOG Cancer Research Network" with 13 trials as a collaborator. Other collaborators include 72 different institutions and companies that were collaborators in the rest 37 trials.

Clinical Trials Conditions at Aurora Bay Area Medical Group-Marinette


According to Clinical.Site data, the most researched conditions in "Aurora Bay Area Medical Group-Marinette" are "Breast Cancer" (31 trials), "Lung Cancer" (19 trials), "Recurrent Ovarian Carcinoma" (18 trials), "Recurrent Fallopian Tube Carcinoma" (13 trials) and "Unspecified Adult Solid Tumor, Protocol Specific" (13 trials). Many other conditions were trialed in "Aurora Bay Area Medical Group-Marinette" in a lesser frequency.

Clinical Trials Intervention Types at Aurora Bay Area Medical Group-Marinette


Most popular intervention types in "Aurora Bay Area Medical Group-Marinette" are "Drug" (308 trials), "Other" (201 trials), "Biological" (132 trials), "Radiation" (81 trials) and "Procedure" (67 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (92 trials), "Quality-of-Life Assessment" (73 trials), "Paclitaxel" (41 trials), "Questionnaire Administration" (41 trials) and "placebo" (31 trials). Other intervention names were less common.

Clinical Trials Genders at Aurora Bay Area Medical Group-Marinette


The vast majority of trials in "Aurora Bay Area Medical Group-Marinette" are 277 trials for "All" genders, 74 trials for "Female" genders and 21 trials for "Male" genders.

Clinical Trials Status at Aurora Bay Area Medical Group-Marinette


Currently, there are NaN active trials in "Aurora Bay Area Medical Group-Marinette". undefined are not yet recruiting, 47 are recruiting, 125 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 172 completed trials in Aurora Bay Area Medical Group-Marinette, 6 suspended trials, and 18 terminated clinical trials to date.
Out of the total trials that were conducted in Aurora Bay Area Medical Group-Marinette, 11 "Phase 1" clinical trials were conducted, 168 "Phase 2" clinical trials and 198 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".